Andrea Rescalli

Mr. Andrea Rescalli

Department of Biomedical Sciences, Humanitas University, Milan, Lombardy, Italy
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2022 in Biosensors
Verified
Journal Article
Open access
PDF file
Andrea RescalliAndrea Rescalli
Andrea Rescalli
Elena Maria VaroniElena Maria Varoni
Elena Maria Varoni
FCFRANCESCO CELLESI
FRANCESCO CELLESI
PCPietro Cerveri
Pietro Cerveri
Diabetes mellitus is a worldwide-spread chronic metabolic disease that occurs when the pancreas fails to produce enough insulin levels or when the body fails to effectively use the secreted pancreatic insulin, eventually resulting in hyperglycemia. Systematic glycemic control is the only procedure at our disposal to prevent diabetes long-term complications such as cardiovascular disorders, kidney diseases, nephropathy, neuropathy, and retinopathy. Glycated albumin (GA) has recently gained more and more attention as a control biomarker thanks to its shorter lifespan and wider reliability compared to glycated hemoglobin (HbA1c), currently the “gold standard” for diabetes screening and monitoring in clinics. Various techniques such as ion exchange, liquid or affinity-based chromatography and immunoassay can be employed to accurately measure GA levels in serum samples; nevertheless, due to the cost of the lab equipment and complexity of the procedures, these methods are not commonly available at clinical sites and are not suitable to home monitoring. The present review describes the most up-to-date advances in the field of glycemic control biomarkers, exploring in particular the GA with a special focus on the recent experimental analysis techniques, using enzymatic and affinity methods. Finally, analysis steps and fundamental reading technologies are integrated into a processing pipeline, paving the way for future point-of-care testing (POCT). In this view, we highlight how this setup might be employed outside a laboratory environment to reduce the time from measurement to clinical decision, and to provide diabetic patients with a brand-new set of tools for glycemic self-monitoring.

15 September 2023 in Chemosensors
Verified
Journal Article
Open access
PDF file
Andrea RescalliAndrea Rescalli
Andrea Rescalli
DMDavide Marzorati
Davide Marzorati
SGSimone Gelosa
Simone Gelosa
FCFRANCESCO CELLESI
FRANCESCO CELLESI
PCPietro Cerveri
Pietro Cerveri
Disease diagnosis through biological fluids, particularly exhaled breath analysis, has gained increasing importance. Volatile organic compounds (VOCs) present in exhaled breath offer diagnostic potential as they reflect altered and disease-specific metabolic pathways. While gas chromatography–mass spectrometry (GC–MS) has been traditionally used for VOCs detection, electronic noses have emerged as a promising alternative for disease screening. Metal oxide semiconductor (MOS) sensors play an essential role in these devices due to their simplicity and cost-effectiveness. However, their limited specificity and sensitivity pose challenges for accurate diagnosis at lower VOCs concentrations, typical of exhaled breath. To address specificity and sensitivity issues, temperature modulation (TM) has been proposed in this paper, introducing a custom-developed electronic nose based on multiple and heterogeneous gas sensors located within an analysis chamber. Four different TM patterns (i.e., square, sine, triangular, and a combination of square and triangular) were applied to the gas sensors to test their response to three different analytes at three distinct concentrations. Data were analyzed by extracting meaningful features from the sensor raw data, and dimensionality reduction using principal component analysis (PCA) was performed. The results demonstrated distinct clusters for each experimental condition, indicating successful discrimination of analytes and concentrations. In addition, an analysis of which set of sensors and modulation pattern yielded the best results was performed. In particular, the most promising TM pattern proved to be the square and triangular combination, with optimal discrimination accuracy between both concentrations and analytes. One specific sensor, namely, TGS2600 from Figaro USA, Inc., provided the best performance. While preliminary results highlighted the potential of TM to improve the sensitivity of gas sensors in electronic nose devices, paving the way for further advancements in the field of exhaled breath analysis.

9 June 2025 in IEEE Sensors Journal
Verified
Journal Article
Closed access
Andrea RescalliAndrea Rescalli
Andrea Rescalli
GVGabriele Vegetali
Gabriele Vegetali
SGSimone Gelosa
Simone Gelosa
FCFRANCESCO CELLESI
FRANCESCO CELLESI
PCPietro Cerveri
Pietro Cerveri
The analysis of biological fluids, particularly exhaled breath (EB), offers a promising non-invasive approach for early disease diagnosis by detecting Volatile Organic Compounds (VOCs). Traditional techniques like Gas Chromatography-Mass Spectrometry (GC-MS), while sensitive, are limited by high costs and complexity. This study explores the application of Temperature Modulation (TM) to enhance the performance of Metal Oxide Semiconductor (MOS) sensors in identifying and quantifying VOCs within complex mixtures. Using a custom-built Electronic Nose (eNose) system equipped with four MOS gas sensors and a square-triangular TM pattern, mixtures of three VOCs, namely acetone, isopropanol, and toluene, were analyzed across three concentration ranges. Sensible parameters extracted from each sensor response were used to discriminate VOCs and concentrations by random forest classifier achieving an accuracy of 91%, precision of 91%, recall of 89%, and F1-score of 89% in classifying the mixtures. Feature re-mapping coupled to a CatBoost classifier leveraging individual VOCs analysis reduced the experimental burden and achieved an 84% classification accuracy. These findings demonstrate that TM combined with Artificial Intelligence (AI) can address key challenges in complex gas mixture analysis, advancing the potential of portable eNose systems for clinical diagnostics.

5 August 2025 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
Andrea RescalliAndrea Rescalli
Andrea Rescalli
DPDavid Probst
David Probst
MHMika Hatada
Mika Hatada
MNMadoka Nagata
Madoka Nagata
FCFRANCESCO CELLESI
FRANCESCO CELLESI
Koji SodeKoji Sode
Koji Sode

25 June 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
Andrea RescalliAndrea Rescalli
Andrea Rescalli
IPIlaria Porello
Ilaria Porello
PCPietro Cerveri
Pietro Cerveri
FCFRANCESCO CELLESI
FRANCESCO CELLESI
Ammonia (NH3) detection in liquids and biological fluids is essential for monitoring environmental contamination and industrial processes, ensuring food safety, and diagnosing health conditions. Existing detection techniques are often unsuitable for point-of-care (POC) use due to limitations including complex sample handling, lack of portability, and poor compatibility with miniaturized systems. This study introduces a proof-of-concept for a compact, portable device tailored for POC detection of gaseous ammonia released from liquid samples. The device combines a polyaniline (PANI)-based chemoresistive sensor with interdigitated electrodes and a resistance readout circuit, enclosed in a gas-permeable hydrophobic membrane that permits ammonia in the vapor phase only to reach the sensing layer, ensuring selectivity and protection from liquid interference. The ink formulation was optimized. PANI nanoparticle suspension exhibited a monomodal, narrow particle size distribution with an average size of 120 nm and no evidence of larger aggregates. A key advancement of this device is its ability to limit the impact of water vapor, a known source of interference in PANI-based sensors, while maintaining a simple sensor design. A tailored signal processing strategy was implemented, extracting the slope of resistance variation over time as a robust metric for ammonia quantification. The sensor demonstrated reliable performance across a concentration range of 1.7 to 170 ppm with strong logarithmic correlation (R2 = 0.99), and very good linear correlations in low (R2 = 0.96) and high (R2 = 0.97) subranges. These findings validate the feasibility of this POC platform for sensitive, selective, and practical ammonia detection in clinical and environmental applications.

22 November 2024 in ECS Meeting Abstracts
Verified
Journal Article
Closed access
Andrea RescalliAndrea Rescalli
Andrea Rescalli
MHMika Hatada
Mika Hatada
FCFrancesco Cellesi
Francesco Cellesi
PCPietro Cerveri
Pietro Cerveri
Koji SodeKoji Sode
Koji Sode
Diabetes mellitus is a prevalent chronic metabolic condition characterized by inadequate insulin production or utilization, leading to elevated blood sugar levels (i.e., hyperglycemia). Effective glycemic control is crucial for preventing long-term complications like cardiovascular disease, kidney disease, neuropathy, and retinopathy. Glycated albumin (GA) is a promising biomarker for glycemic control due to its shorter lifespan and broader reliability compared to glycated hemoglobin (HbA1c), which is the gold standard glycated biomarker widely used in clinical practice. By reflecting the average blood glucose level of the previous 2-3 weeks, as opposed to the 2-3 months of HbA1c, GA allows for better tracking of rapidly evolving conditions. Moreover, it is not affected by hematologic disorders which can bias HbA1c measurements. GA is defined as the fraction of glycated human serum albumin (GHSA) to total human serum albumin (HSA). At present, GHSA is assessed at central laboratories using enzymatic assay kits that rely on spectroscopical measurements and include fructosyl amino-acid oxidase, which requires the proteolytic hydrolysis of GHSA to release fructosyl amino acid. Nevertheless, the need for a pre-treatment of GHSA poses a big challenge in the translation of this technique outside a laboratory setting. Therefore, a point-of-care testing (POCT) platform that minimizes the time gap between measurement and clinical decision-making, and expands the tools available to diabetic subjects for self-monitoring of their blood sugar levels management is needed [1, 2]. Aptamers are a type of single-stranded oligonucleotide that are able to selectively interact with a wide range of target molecules. They are chemically synthesized, possess great thermal stability and exhibit regenerable binding [3, 4]. The aptamer against intact GHSA has been reported [5], thus eliminating the need for a pre-digestion of the GHSA and empowering POCT applications. Aptamer-based detection of HSA has also been successfully achieved [6]. The clinical relevance for GA as a biomarker relies on the percentage ratio quantification of GHSA to the total HSA present in the plasma. Another problem of current spectroscopic techniques is that GHSA and HSA levels are assessed with two distinct assays (i.e., enzymatic for GHSA and bromocresol purple for HSA), which are difficult to combine into a single platform. Hence, for effective implementation of a POCT or personal sensing device it should be able to measure both GHSA and total HSA on the same unit. In this work we aim to expand on a recent design of our research group [7], in which two aptamer-based extended gate field effect transistor (EGFET) sensors were developed in parallel: one dedicated to GHSA measurement and a second one to quantify total HSA. GHSA was successfully detected in concentrations from 0.1 to 10 μM within 20 minutes, even in presence of bovine serum albumin. Total HSA concentrations ranging from 1 to 17 μM were correctly measured. Furthermore, the linear calibration curves obtained with each sensor allowed to correctly quantify glycation ratios in samples with known and clinically relevant GA levels. The aim of this work is to develop a novel GA sensing technique exploiting a single sensor with dual electrochemical modalities, which are based on square wave voltammetry (SWV) and EGFET. In this scenario, separating the signal contribution of each aptamer from the total is of critical importance. To achieve this, we propose to interrogate each recognition element with a different electrochemical technique. SWV is used to detect the change in electron transfer kinetics of the redox probe covalently attached on one aptamer. For the second aptamer, the EGFET configuration that we have already successfully reported is implemented to detect the non-faradaic contribution of charge variations at the surface of the extended gate. The combination of these two techniques could lead to the dual measurement of GHSA and HSA at the single sensor, enabling the development of an all-in-one POCT platform for glycemic control in diabetic subjects. References [1] Rescalli et al., Biosensors, 2022, 12(9), 687 [2] Hatada et al., Sensors and Actuators, B: Chemical, 2022, 130914 [3] Xiao et al., Angewandte Chemie International Edition, 2005, 44, 5456-5459 [4] Wu et al., Analytical Chemistry, 2022, 94(23), 8335-8345 [5] Apiwat et al., Biosensors and Bioelectronics, 2016, 82, 140-145 [6] Japrung et al., 2017, U.S. Patent No. 9,834,772 [7] Hatada et al., Biosensors and Bioelectronics, 2024, 116118